glp-1 shortage Diabetes Patients Also Struggle to Access Agonists What happens when demand outpaces
Description
Endocrinology 160 , 24172426 (2019)
Insurance will typically only cover the cost of semaglutides if the patient is diabetic, not for weight loss reasons
Bariatric Surgery Vs
The result is predictable
Stock levels of Trulicity, manufactured by US company Eli Lilly, were reported to be fully restocked by March 2023
The same effect could be observed with a 2-week des-fluoro-sitagliptin treatment leading to increased insulin exocytosis by cells from db / db diabetic mice (133)
